Navigation Links
PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
Date:3/10/2008

ANNAPOLIS, Md., March 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and Chief Executive Officer of PharmAthene, will present at the Cowen and Company 28th Annual Health Care Conference in Boston on Tuesday, March 18, 2008 at 8:45 a.m. The presentation is scheduled to take place in the Vineyard Room at the Boston Marriott Copley Place hotel.

PharmAthene's presentation will be available via webcast on the company's website at http://www.pharmathene.com. A link to access the webcast will be accessible from both the homepage and the investor relations pages of the PharmAthene corporate website. For assistance, contact Stacey Jurchison at 410-269-2610.

About PharmAthene, Inc.

PharmAthene (Amex: PIP) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.pharmathene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
9. Avicena Group to Present at Noble Financial Conference
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... February 18, 2020 , ... Intech ... launch of a new and unified global brand identity, as it celebrates its ... engineering challenges, as well as an enthusiasm for designing and manufacturing state-of-the-art medical ...
(Date:2/11/2020)... ... 11, 2020 , ... Synagro Technologies, Inc. , the ... that the City of Fort Worth has partnered with Synagro of Texas-CDR (Synagro) ... of 2020, Synagro will assume operation of the city’s current biosolids management facility ...
(Date:2/3/2020)... ... 2020 , ... Ovation Travel Group has published ... Travel and Biotech/Healthcare Industry Travel Indexes. , All of the Indexes contain three ... Average airfare price paid Domestically, Internationally and Overall , ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an ... new Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year ... researchers can extend the accuracy and ease of use of salivary bioscience into ...
Breaking Biology Technology:
(Date:2/13/2020)... Fla. (PRWEB) , ... February 13, 2020 , ... ... Annual SCOPE Summit , geared to clinical operations executives and focusing on all ... of effective project management, portfolio management, patient engagement, and more. , “We ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... complex problems for life sciences companies and government agencies, announced the recent ... management consulting expertise to Tunnell, with significant experience assessing, designing, and managing ...
(Date:2/7/2020)... ... 2020 , ... dicentra , a leading clinical research ... dietary supplement industries, announces 2020 membership with the International Probiotics Association (“IPA”). ... to probiotics. We are thrilled to join our IPA member colleagues and bring ...
Breaking Biology News(10 mins):